ABC-08, A phase 1b multi-centre, open-label study of a first-in-class nucleotide analogue Acelarin (NUC-1031) in combination with cisplatin in patients with locally advanced/metastatic biliary tract cancers

Internal description

Research Project Agreement [RPA]
Short titleP:KBF ABC-08, A phase 1b
Effective start/end date23/12/1531/03/20